DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,895,000 | +11.1% | 143,589 | +105.7% | 0.02% | +25.0% |
| Q2 2021 | $2,606,000 | -15.0% | 69,820 | -41.7% | 0.02% | -23.8% |
| Q1 2021 | $3,065,000 | +519.2% | 119,857 | +433.3% | 0.02% | +320.0% |
| Q4 2020 | $495,000 | -62.9% | 22,473 | -69.7% | 0.01% | -68.8% |
| Q3 2020 | $1,334,000 | +90.6% | 74,162 | +169.2% | 0.02% | +60.0% |
| Q2 2020 | $700,000 | +8.2% | 27,551 | -6.2% | 0.01% | 0.0% |
| Q4 2019 | $647,000 | -38.5% | 29,364 | -59.9% | 0.01% | -37.5% |
| Q3 2019 | $1,052,000 | +4.5% | 73,246 | +14.6% | 0.02% | -11.1% |
| Q2 2019 | $1,007,000 | +8.7% | 63,923 | +1.1% | 0.02% | +20.0% |
| Q1 2019 | $926,000 | – | 63,242 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 2,005,238 | $16,463,000 | 5.12% |
| Abingworth LLP | 945,757 | $7,755,000 | 4.53% |
| RA Capital Management | 2,428,571 | $19,939,000 | 2.86% |
| Omega Fund Management, LLC | 223,457 | $1,835,000 | 1.03% |
| DAFNA Capital Management LLC | 123,500 | $1,014,000 | 1.01% |
| Iguana Healthcare Management, LLC | 100,000 | $821,000 | 0.32% |
| Cormorant Asset Management, LP | 245,000 | $2,011,000 | 0.32% |
| Eventide Asset Management | 315,300 | $2,589,000 | 0.15% |
| AWM Investment Company, Inc. | 80,000 | $657,000 | 0.13% |
| Palo Alto Investors LP | 267,890 | $2,199,000 | 0.11% |